CClinicalTrials.gg
CompletedNCT04020432ECOFPUpdated Mar 22, 2023

Knowledge Assessment of Women About Pictograms Associated With the Danger of Medicines Taken During Pregnancy

An observational study in Knowledge, Attitudes, Practice and Pregnancy Related, sponsored by Centre Hospitalier Universitaire, Amiens. Completed at 1 site in France. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-03-22.

Sponsored by Centre Hospitalier Universitaire, Amiens · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
281
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

Women's awareness about the danger of certain medicines taken during pregnancy presents a real public health issue. To enhance awareness and information for women and healthcare professionals, new pictograms " pregnant women " appeared on medication boxes, on October 16, 2017. These new pictograms can change women's perception of self-medication during pregnancy and of the danger of taking certain medicines for the unborn development. Furthermore, the investigators can wonder if the meaning of these pictograms is well understood. Therefore, the study's primary aim is to assess the knowledge of pregnant or childbearing age women about the pictograms associated with the danger of certain medicines taken during pregnancy.

02

Conditions studied

  • Knowledge, Attitudes, Practice
  • Pregnancy Related

Keywords

  • knowledge
  • medicine
  • pictogram
  • pregnant woman
  • childbearing age woman
03

In context

Lead sponsor

Centre Hospitalier Universitaire, Amiens is the lead sponsor of 576 studies on the registry; 178 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

pregnant or childbearing age women between 18 and 45 years old.

Inclusion criteria

  • women who agree to participate to the study
  • women who understand french language (oral and written)
  • pregnant women and women of childbearing age from 18 to 45 years old.

Exclusion criteria

Exclusion Criteria:

  • Women who have already answered the questionnaire
  • women who don't want to answer the questionnaire
  • women who don't understand french language
  • women who are under the age of 18 or over the age of 45
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
281 participants (actual)
Patient registry
No

Groups and cohorts

  • pregnant women

    Pregnant women are coming to their monthly consultation. A quantitative questionnaire has been created under primary and secondary assumptions. Questionnaires are going to be distributed to women who are agree to participate to this study. The questionnaires are going to be delivered by the investigators. Pregnant women can answer the questionnaire in the waiting room of consultation's services. The questionnaire will be anonymous and the return of questionnaires will be made personally.

    Behavioral: questionary

  • childbearing age women

    Women of childbearing age, who are coming for a gynecological consultation. A quantitative questionnaire has been created under primary and secondary assumptions. Questionnaires are going to be distributed to women who are agree to participate to this study. The questionnaires are going to be delivered by the investigators. Childbearing age women can answer the questionnaire in the waiting room of consultation's services. The questionnaire will be anonymous and the return of questionnaires will be made personally.

    Behavioral: questionary

Interventions

  • Behavioralquestionary

    A quantitative questionnaire has been created under primary and secondary assumptions. Questionnaires are going to be distributed to women who are agree to participate to this study. The questionnaires are going to be delivered by the investigators. Women can answer the questionnaire in the waiting room of consultation's services. The questionnaire will be anonymous and the return of questionnaires will be made personally.

06

What researchers measure

Primary outcomes

  1. Medication pictogram women knowledge measure

    Determination of women knowledge about pictograms associated with the danger of certain medicines during pregnancy by analysing the questionnaire responses

    Time frame: day 0

Secondary outcomes

  1. Medication pictogram women information measure

    Determination of women information about pictograms associated with the danger of certain medicines during pregnancy by analysing the questionnaire responses

    Time frame: day 0

07

Study locations

1 site
  • CHU Amiens
    Amiens, 80000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 22, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04020432
Lead sponsor
Centre Hospitalier Universitaire, Amiens
Collaborators
Centre Hospitalier HIRSON
Responsible party
Sponsor
First posted
Jul 16, 2019
Start date
Jul 11, 2019
Primary completion
Dec 11, 2019
Completion
Dec 11, 2021
Last update
Mar 22, 2023

Study contacts

Alice Rousseaux
principal investigator · CH Hirson

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion